A Comparison of a Moderate with Moderate-high Intensity Oral Anticoagulant Treatment in Patients with Mechanical Heart Valve Prostheses
- 1 May 1997
- journal article
- clinical trial
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 77 (05) , 0839-0844
Abstract
Summary: Background. The long-term administration of oral anticoagulants to patients with mechanical heart valve prostheses is generally accepted. However, the appropriate intensity of oral anticoagulant treatment in these patients is still controversial.Methods and Results. From March 1991 to March 1994, patients referred to the Padova Thrombosis Center who had undergone mechanical heart valve substitution at least 6 months earlier were randomly assigned to receive oral anticoagulants at moderate intensity (target INR = 3) or moderate-high intensity (target INR = 4). Principal end points were major bleeding, thromboembolism and vascular death. Minor bleeding was a secondary end-point.A total of 104 patients were assigned to the target 3 group and 101 to the target 4 group; they were followed for from 1.5 years to up 4.5 years (mean, 3 years). Principal end-points occurred in 13 patients in the target 3 group (4 per 100 patient-years) and in 20 patients in the target 4 group (6.9 per 100 patient-years). Major hemorrhagic events occurred in 15 patients, 4 in the target 3 group (1.2 per 100 patient-years) and 11 in the target 4 group (3.8 per 100 patient-years) (p = 0.019). The 12 recorded episodes of thromboembolism, 4 of which consisted of a visual deficit, were all transient ischemic attacks, 6 in the target 3 group (1.8 per 100 patient-years) and 6 in the target 4 group (2.1 per 100 patient- years). There were 3 vascular deaths in each group (0.9 and 1 per 100 patient-years for target 3 and target 4 groups, respectively). Minor bleeding episodes occurred 85 times (26 per 100 patient-years) in the target 3 group and 123 times (43 per 100 patient-years) in the target 4 group (p = 0.001).Conclusions. Mechanical heart valve patients on anticoagulant treatment who had been operated on at least 6 months earlier experienced fewer bleeding complications when maintained on a moderate intensity regimen (target INR = 3) than those on a moderate-high intensity regimen (target INR = 4). The number of thromboembolic events and vascular deaths did not differ between the two groups.Keywords
This publication has 17 references indexed in Scilit:
- Therapeutic target values in oral anticoagulation — Justification of Dutch policy and a warning against the so-called moderate-intensity regimensAnnals of Hematology, 1992
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990
- RATES OF THROMBOEMBOLISM WITH THREE DIFFERENT MECHANICAL HEART VALVE PROSTHESES: RANDOMISED STUDYThe Lancet, 1989
- Prevention of Thromboembolism Induced by Prosthetic Heart ValvesSeminars in Thrombosis and Hemostasis, 1988
- Thrombotic and Bleeding Complications of Prosthetic Heart ValvesThe Annals of Thoracic Surgery, 1987
- PROGRESS IN LABORATORY CONTROL OF ORAL ANTICOAGULANTSThe Lancet, 1982
- CAN ACETYLSALICYLIC ACID ALONE PREVENT ARTERIAL THROMBOEMBOLISM? A PILOT STUDY IN PATIENTS wITH AORTIC BALL VALVE PROSTHESESActa Medica Scandinavica, 1981
- Thromboembolic Complications of Prosthetic Cardiac ValvesCirculation, 1968
- Influence of Rhythm and Anticoagulation upon the Incidence of Embolization Associated with Starr-Edwards ProsthesesCirculation, 1967
- Factors Affecting Thromboembolism Associated with Prosthetic Heart ValvesCirculation, 1967